Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Green, Susi ^b   Tawil, Ashref ^c   Barr, Hugh ^d   Bennett, Cathy ^e   Bhandari, Pradeep ^b   DeCaestecker, John ^c   Ragunath, Krish ^f   Singh, Rajvinder ^g   Jankowski, Janusz ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f QUEEN S MEDICAL CENTRE   (United Kingdom)

^g LYELL MCEWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS LEAKAGE; ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CAUTERIZATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EARLY CANCER; EMPYEMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; ESOPHAGUS SURGERY; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; LOW LEVEL LASER THERAPY; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PHOTODYNAMIC THERAPY; PLEURA EFFUSION; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE INFECTION; PROGRESSION FREE SURVIVAL; PULMONARY ASPIRATION; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL INFECTION; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 70349130008     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007334.pub2     Document Type: Review

References (85)

1. Das A, Singh A, Fleischer D, Sharma V. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology 2008;103:1340-1345 (Pubitemid 351813937)
2. Pacifico RJ, Wang KK, Wongkeesong L, Buttar NS, Lutzke LS. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy of early adenocarcinoma in Barrett's esophagus. Clinical Gastroenterology and Hepatology 2003;1:252-257 (Pubitemid 37254451)
3. Prasad G, Wang K, Buttar N, Wongkeesong L, Krishnadath K, Nichols F, et al.Long-term survival following endoscopic and surgical treatment of high-grade dyplasia in Barrett's esophagus. Gastroenterology 2007;132:1226-1233 (Pubitemid 46627583)
4. Reed MF, Tolis G, Edil BH, Allan JS, Donahue DM, Gaissert HA, et al.Surgical treatment of esophageal high-grade dysplasia. Annals of Thoracic Surgery 2005;79:1110-1115
5. Schembre D, Huang J, Lin O, Cantone N, Low D. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Clinical Endoscopy 2008;67(4):595-601.
6. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Esophageal stripping with preservation of the vagus nerve. International Surgery 1982;2:125-128 (Pubitemid 12014089)
7. Attwood S, Lewis C, Caplin S, Hemming K, Armstrong G. Argon beam photocoagulation as therapy for high grade dysplasia in Barrett's esophagus. Clinical Gastroenterology and Hepatology 2003;1(4):258-263 (Pubitemid 37254452)
8. Auger CP. Information sources in grey literature. 4th Edition. London: Bowker-Saur, 1998.
9. Banki F, Mason RJ, Hagen JA, Balaji NS, Crookes PF, Bremner CG, et al.Vagal-sparing esophagectomy: a more physiologic alternative. Annals of Surgery 2002;236(3):324-336 (Pubitemid 34971342)
10. Basu KK, Pick B, de Caestecker JS. Audit of a Barrett's epithelium surveillance database. European Journal of Gastroenterology and Hepatology 2004;16:1-5. (Pubitemid 39049653)
11. Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA. The histopathology of treated Barrett's Oesophagus: squamous re-epithelialisation following acid suppression, laser and photodynamic therapy. American Journal of Surgical Pathology 1998;22(2):239-245 (Pubitemid 28113386)
12. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Wennberg DE, et al.Hospital volume and surgical mortality in the United States. New England Journal of Medicine 2002;346(15):1128-1137 (Pubitemid 34984604)
13. Blazeby J. Medicinal herbs for esophageal cancer [comment]. Cochrane Database of Systematic Reviews 2007. [DOI: 10.1002/14651858.CD004520.pub3]
14. Bronner MP, Overholt BF, Taylor SL, Haggitt R, Wang K, Burdick JS, et al.Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 2009;136(1):56-64.
15. Brown LM, Swanson CA, Gridley G, Swanson GM, Silverman DT, Greenberg RS, et al.Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States. Cancer Causes and Control 1998;9(5):467-474 (Pubitemid 29026910)
16. Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, et al.Extent of high grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-1639
17. Byrne JP, Mathers JM, Parry JM, Attwood SEA, Bancewicz J, Woodman CBJ. Site distribution of oesophageal cancer. Journal of Clinical Pathology 2002;55:191-194
18. Caldwell MT, Lawlor P, Byrne PJ, Walsh TN, Hennessy TP. Ambulatory oesophageal bile reflux monitoring in Barretts oesophagus. British Journal of Surgery 1995;82:657-660
19. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) oesophagus. Comparison of population based clinical and autopsy findings. Gastroenterology 1990;99(4):918-922
20. Chak A, Lee T, Kinnard M, Brock W, Faulx A, Willis J, et al.Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 2002;51(3):323-328 (Pubitemid 34907697)
21. Chen ZM, Xu Z, Collins R, Li W-X, Peto R. Early health effects of the emerging tobacco epidemic in China: A 16-year prospective study. Journal of the American Medical Association 1997;278:1500-1504 (Pubitemid 27488277)
22. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, et al.Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007;133:34-41. (Pubitemid 47031134)
23. Cancer Research UK. UK Oesophageal cancer incidence statistics. http://info.cancerresearchuk.org/cancerstats/types/oesophagus/incidence/?a=5441 (accessed 17 February 2009).
24. de Vries DR, ter Linde JJM, van Herwaarden MA, Smout AJPM, Samsom M. Gastroesophageal reflux disease is associated with the C825T polymorphism in the g-protein 3 subunit gene (GNB3). American Journal of Gastroenterology 2009;104:281-285
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-188
26. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007;133(2):403-411 (Pubitemid 47187351)
27. Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D'haese S, et al.Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials-does HRQOL evaluation in prostate cancer research inform clinical decision making?. Journal of Clinical Oncology 2003;18:3502-3511 (Pubitemid 46594084)
28. Ell C, May A, Gossner L, Pech O, Guntner E, Mayer G, et al.Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677 (Pubitemid 30171616)
29. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, et al.Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Clinical Endoscopy 2007;65(1):3-10.
30. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford LM, et al.Population attributable risks of esophageal and gastric cancers. Journal of the National Cancer Institute 2003;95:1404.
31. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high grade dysplasia. Gastrointestinal Endoscopy 1999;49:170-176
32. Giovannini M, Bories E, Pesenti C, Mountardier V, Monges G, Danisi C, et al.Circumferenctial endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer, preliminary results in 21 patients. Endoscopy 2004;36(9):782-787 (Pubitemid 39207151)
33. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, et al.Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008;40(5):359-369 (Pubitemid 351696372)
34. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, et al.Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008;40(5):370-379 (Pubitemid 351696373)
35. Greenstein A, Wisnivesky J, Litle V. Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. Diseases of the Esophagus 2008;21(8):673-8. [DOI: DOI 10.111/j.1442-2050.2008.00832]
36. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Annals of Internal Medicine 2005;143(3):199-211. (Pubitemid 41076753)
37. Hellier MD, Sanderson JD, Morris AI, Elias E, De Caestecker J. Care of patients with gastrointestinal disorders in the United Kingdom: a strategy for the future. http://www.bsg.org.uk/pdf-word-docs/strategy06-final.pdf (accessed 12 February 2009).
38. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
39. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus. British Journal of Surgery 1997;84:1470-1473
40. Hornick JL, Blount PL, Sanchez CA, Cowan DS, Ayub KM, Maley CC, et al.Biological properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. American Journal of Surgical Pathology 2005;29:372-380
41. Hornick JL, Mino-Kenudson M, Lauwers GY, Liu W, Goyal R, Odze RD. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. American Journal of Gastroenterology 2007;103(1):38-47.
42. Hulscher F, van Sandick J, de Boer A, Wijnhoven B, Tijssen J, Fockens P. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine 2002;347:1662-1669 (Pubitemid 35340784)
43. Hung HC, Huang MC, Lee JM, Wu DC, Hsu HK, Wu MT. Association between diet and esophageal cancer in Taiwan. Journal of Gastroenterology and Hepatology 2004;19(6):632-637
44. Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Digestive Diseases and Sciences 2003;48:1273-1283 (Pubitemid 36793904)
45. Jamieson G, Mathew G, Ludemann R, Wayman J, Myers J, Devitt P. Postoperative mortality following oesophagectomy and problems in reporting its rate. British Journal of Surgery 2004;5:943-947 (Pubitemid 39070806)
46. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al.Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the oesophagus. American Journal of Pathology 1995;154:965-973
47. Keeley SB, Pennathur A, Gooding W, Landreneau RJ, Christie NA, Luketich J. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. American Journal of Surgical Oncology 2007;14(8):2406-2410
48. Kelty CJ, Gough MD, Van Wyk Q, Stephenson TJ, Ackroyd R. Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk. Scandinavian Journal of Gastroenterology 2007;42(11):1271-1274 (Pubitemid 47537076)
49. Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K, et al.Is the risk of concomitant invasive esophageal cancer in high grade dysplasia in Barrett's esophagus overestimated?. Clin Exp Pathol 2008;6(2):159-164
50. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux is a strong risk factor for esophageal adenocarcinoma. New England Journal of Medicine 1999;340:825-831 (Pubitemid 29142625)
51. Lagergren J, Ye W, Lindgren A, Nyrén O. Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiology, Biomarkers and Prevention 2002;9:757-760
52. Liu W, Hahn Hodze RD, Goyal RK. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell containing epithelium. American Journal of Gastroenterology in press.
53. May A, Gossner L, Pech O, Fritz A, Gunter E, Mayer G, et al.Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus :acute phase and intermediate results of a new treatment approach. European Journal of Gastroenterology 2002;14:1085-1091
54. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, et al.Mortality rates in patients with Barrett's oesophagus. Alimentary Pharmacology and Therapeutics 2008;27(4):316-320
55. Morita M, Kuwano H, Ohno S, Sugimachi K, Seo Y, Tomoda H, et al.Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. International Journal of Cancer 1994;58:207-210 (Pubitemid 24240097)
56. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high grade dysplasia within Barrett's esophagus. Gastrointestinal Endoscopy 2000;52:328-332
57. Overholt B, Wang K, Burdick S, Lightdale C, Kimmey M, Nava H, et al.Five-year efficacy and safety of photodynamic therapy with photofrin in Barrett's high-grade dysplasia. Clinical Endoscopy 2007;66(3):460-468 (Pubitemid 47304412)
58. Pech O, Behrens A, May A, Gossner L, Vieth M, Stolte M, et al.Curative endoscopic therapy for Barrett's early cancer and high grade dysplasia: long-term results in 304 patients. Gastrointestinal Endoscopy 2006;63(5):AB83.
59. Pech O, May A, Rabenstein T, Ell C. Endoscopic resection of early oesophageal cancer. Gut 2007;56:1625-1634
60. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al.Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57:1200-1206
61. Peters FP, Kara MA, Rosmolen WD, Ten Kate FJW, Krishnadath KK, Lanschot JJB, et al.Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. American Journal of Gastroenterology 2006;101:1449-1457
62. Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 2006;55:442-443
63. Romero Y, Cameron A, Scaid D, McDonnell S, Burgart L, Hardtke C, et al.Barrett's esophagus: prevalence in symptomatic relatives. American Journal of Gastroenterology 2002;97(5):1127-1132 (Pubitemid 34478109)
64. Ronikainen J, Aro P, Storskrubb T, Johansson S, Lind T, Bolling-Sternevold E, et al.Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-1831 (Pubitemid 41772961)
65. Rouvelas I, Jia C, Viklund P, Lindblad M, Lagergren J. Surgeon volume and postoperativemortality after oesophagectomy for cancer. European Journal of Surgical Oncology 2007;33(2):162-168 (Pubitemid 46336556)
66. Rösch T. BARRx for total Barrett's eradication - the new super weapon?. Endoscopy 2008;40(5):393-394 (Pubitemid 351696376)
67. Sampliner R, Fennerty MB, Garewal H. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation. Gastrointestinal Endoscopy 1996;44:523-525
68. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, et al.Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1608-1619 (Pubitemid 32523480)
69. Shaheen NJ, Inadomi JM, Overholt BF, Shamra P. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 2004;53:1736-1744
70. Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ, et al.Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointestinal Endoscopy 2007;65(2):185-195 (Pubitemid 46157125)
71. Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Gastrointestinal Endoscopy 2008;40(5):380-387
72. Sharma VK, Jae Kim H, Das A, Wells CD, Nguyen CC, Fleischer DE. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. American Journal of Gastroenterology 2009;104(2):310-317
73. Singh S, Sharma P. How effective is endoscopic therapy in the treatment of patients with early esophageal cancer?. Nature Clinical Practice Gastroenterology & Hepatology 2009;6(2):70-71
74. Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low grade dysplasia in Barrett's esophagus and its implication for disease progression. American Journal of Gastroenterology 2000;95(12):3383-3387
75. Stein HJ, Feith M, Bruecher BLDM, Naehrig J, Sarbi M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Annals of Surgery 2005;242(4):566-573 (Pubitemid 41428652)
76. Stein HJ, Hutter J, Feith M, von Rahden BH. Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Seminars in Thoracic and Cardiovascular Surgery 2007;19(1):72-78 (Pubitemid 46488830)
77. Thomas P, Doddoli C, Neville P, Pons J, Lienne P, Giudicelli R, et al.Esophageal cancer resection in the elderly. European Journal of Cardiothoracic Surgery 1996;11:941-946
78. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, et al.Alcohol consumption and mortality among middle-aged and elderly U.S. adults. New England Journal of Medicine 1997;337:1705. (Pubitemid 27527766)
79. Urba SG, Orringer MB, Turrisi A, Lannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. Journal of Clinical Oncology 2001;19:305-313 (Pubitemid 32112841)
80. Vaezi MF, Richter JE. Synergsm of acid and duodenogastroesophageal reflux in complicated Barrett oesophagus. Surgery 1995;117:699-704.
81. Vij R, Triadafilopoulos G, Owens DK, Kunz P, Sanders GD. Costeffectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointestinal Endscopy 2004;60(5):739-756 (Pubitemid 39550931)
82. Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. International Journal of Cancer 2002;99(6):860-868
83. Wani S, Mathur S, Sharma P. How to manage a Barrett's esophagus patient with low-grade dysplasia. Clinical Gastroenterology and Hepatology 2009;1:27-32.
84. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Annals of Surgery 2001;233(3):338-344 (Pubitemid 32187811)
85. Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Cotelingam JD, et al.Barrett's esophagus. A prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-124 (Pubitemid 17207669)